Luxiq (betamethasone valerate) Foam
Company: Connetics CorporationApproval Status: Approved June 1999
Treatment for: Dermatology
Areas: Dermatology / Plastic Surgery
General Information
Luxiq (betamethasone valerate) Foam has been approved for the treatment of dermatoses of the scalp.
Luxiq Drug Information
The Luxiq drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
